Ignite Creation Date:
2025-12-24 @ 10:24 PM
Ignite Modification Date:
2026-03-07 @ 11:01 PM
Study NCT ID:
NCT02671435
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-22
First Post:
2016-01-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
Sponsor:
MedImmune LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D419NC00001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None